These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21595802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients.
    Ribolsi M, Emerenziani S, Borrelli O, Balestrieri P, Addarii MC, Petitti T, Cicala M.
    Scand J Gastroenterol; 2012 Nov; 47(11):1266-73. PubMed ID: 22954058
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V.
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [Abstract] [Full Text] [Related]

  • 5. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring.
    Vaezi MF, Schroeder PL, Richter JE.
    Am J Gastroenterol; 1997 May; 92(5):825-9. PubMed ID: 9149194
    [Abstract] [Full Text] [Related]

  • 6. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M, Conigliaro R, Mirante VG, Melotti G.
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [Abstract] [Full Text] [Related]

  • 7. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 8. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K, Duan LP, Ge Y, Xu ZJ, Xia ZW.
    Zhonghua Yi Xue Za Zhi; 2011 May 17; 91(18):1228-32. PubMed ID: 21756791
    [Abstract] [Full Text] [Related]

  • 12. Precise role of acid in non-erosive reflux disease.
    Wang C, Hunt RH.
    Digestion; 2008 May 17; 78 Suppl 1():31-41. PubMed ID: 18832838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E, Zentilin P, Tutuian R, Pohl D, Casa DD, Frazzoni M, Cestari R, Savarino V.
    Am J Gastroenterol; 2008 Nov 17; 103(11):2685-93. PubMed ID: 18775017
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE, Chehade R, Crowell MD.
    Am J Gastroenterol; 2011 Sep 17; 106(9):1604-11. PubMed ID: 21691342
    [Abstract] [Full Text] [Related]

  • 17. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA.
    Rev Gastroenterol Mex; 2003 Sep 17; 68(2):113-9. PubMed ID: 15127647
    [Abstract] [Full Text] [Related]

  • 18. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R, Bautista JM, Wong WM, Bhatt R, Beeler JN, Malagon I, Risner-Adler S, Lam KF, Fass R.
    Am J Gastroenterol; 2006 Nov 17; 101(11):2463-9. PubMed ID: 17090277
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T.
    J Gastroenterol Hepatol; 2012 Apr 17; 27 Suppl 3():58-62. PubMed ID: 22486873
    [Abstract] [Full Text] [Related]

  • 20. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K, Boecxstaens V, Van Oudenhove L, Farré R, Boeckxstaens G, Tack J.
    Neurogastroenterol Motil; 2011 Aug 17; 23(8):724-e327. PubMed ID: 21535319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.